Bendamustine in Acute Leukemia and MDS

Clinical trial NCT00790855 · TERMINATED

Trial details

NCT number: NCT00790855
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndrome Acute Lymphoblastic Leukemia Chronic Myeloid Leukemia

Start date: 2008-11-01
Primary completion: 2012-03-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.